MedTrace Logo

Acute Renal Injury After Major Elective Non-Cardiac Surgery

NCT04600271 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 425

Last updated 2021-09-22

No results posted yet for this study

Summary

The study is planned to be a single-center study and includes patients who underwent major surgery within Istanbul University Istanbul Faculty of Medicine with an invasive arterial line. Our aim to define the incidence of acute renal injury in our setting and to investigate the risk factors listed in detailed description. After obtaining written informed consent from the patients, preoperative risk factors will be notes. Following standard anesthesia monitoring as well as routine anesthesia induction and maintenance, invasive arterial monitoring will be performed due to the major surgery and hemodynamic values will be recorded throughout the surgery. The primary outcome will be acute renal injury based on KDIGO's (Kidney Disease: Improving Global Outcomes) definition of acute renal damage. Postoperative data regarding this outcome as well as additional data listed in detailed description will be collected.

Conditions

  • Acute Renal Injury

Interventions

DRUG

Crystalloid Solutions

exposure

DRUG

Colloid Blood Volume Expanders

exposure

OTHER

blood replacement

exposure

DRUG

Diuretic

exposure

DRUG

noradrenaline

exposure

DRUG

Non-Steroidal Anti-Inflammatory Analgesics

exposure

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Mukadder Orhun Sungur, Assos. Prof. · Istanbul University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-11-01
Completion
2021-02-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04600271 on ClinicalTrials.gov